News
RWD utilization in Medical DX Practices
Co-hosted webinar by DAIICHI SANKYO COMPANY, LIMITED and MDV On Nov. 22nd, 2022
- November 2, 2022
Medical Data Vision Co., Ltd. (Chiyoda-ku, Tokyo, President: Hiroyuki Iwasaki, hereinafter “MDV”) and DAIICHI SANKYO COMPANY, LIMITED (Chuo-ku, Tokyo; President and CEO: Jun Manabe) announced today that on November 22, 2022, will be co-hosted a webinar (in Japanese) entitled “RWD utilization in Medical DX Practices”. If you wish to watch the webinar, please register by accessing the below registration URL or the “QR code”.
Webinar Information
- Time / Date
Tuesday, November 22nd, 2022, 15:00-16:00 - Theme
RWD utilization in Medical DX Practices - Topics
- Introduction of MDV Services and Products
- Presentation by DAIICHI SANKYO COMPANY, LIMITED
Utilization of the annual all therapeutics data provision at Daiichi Sankyo Company, Limited
- Speakers
Mr. Atsushi Takita
RWD Evidence Group, Data Intelligence Dep., DAIICHI SANKYO COMPANY, LIMITED
Mr. Yugo Hino
Technical Lead of IDAP, Digital Transformation Planning Dep., DAIICHI SANKYO COMPANY, LIMITED - Target audience
Persons employed by pharmaceutical or medical device companies, insurance companies, or research institutions.
*Those ineligible may not apply for this webinar - How to watch
Online webinar
*details will be sent to the registered email address - Registration Fee
Free
Content
DAIICHI SANKYO, which has been strongly leveraging data and digital technology to promote DX (Digital Transformation), will present a case study of its utilization of Medical Data Vision’s medical database, Which is one of the largest medical databases in Japan.